24 research outputs found

    Sulfatide-Hsp70 Interaction Promotes Hsp70 Clustering and Stabilizes Binding to Unfolded Protein

    No full text
    The 70-kDa heat shock protein (Hsp70), one of the major stress-inducible molecular chaperones, is localized not only in the cytosol, but also in extracellular milieu in mammals. Hsp70 interacts with various cell surface glycolipids including sulfatide (3'-sulfogalactosphingolipid). However, the molecular mechanism, as well as the biological relevance, underlying the glycolipid-Hsp70 interaction is unknown. Here we report that sulfatide promotes Hsp70 oligomerization through the N-terminal ATPase domain, which stabilizes the binding of Hsp70 to unfolded protein in vitro. We find that the Hsp70 oligomer has apparent molecular masses ranging from 440 kDa to greater than 669 kDa. The C-terminal peptide-binding domain is dispensable for the sulfatide-induced oligomer formation. The oligomer formation is impaired in the presence of ATP, while the Hsp70 oligomer, once formed, is unable to bind to ATP. These results suggest that sulfatide locks Hsp70 in a high-affinity state to unfolded proteins by clustering the peptide-binding domain and blocking the binding to ATP that induces the dissociation of Hsp70 from protein substrates

    Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis

    No full text
    Glucagon-like peptide-1 (GLP-1) receptor agonists are used to treat diabetes, but their effects on nonalcoholic steatohepatitis (NASH) and the development of hepatocellular carcinoma (HCC) remain unclear. In this study, mice with streptozotocin- and high-fat diet-induced diabetes and NASH were subcutaneously treated with liraglutide or saline (control) for 14 weeks. Glycemic control, hepatocarcinogenesis, and liver histology were compared between the groups. Fasting blood glucose levels were significantly lower in the liraglutide group than in the control group (210.0 ± 17.3 mg/dL vs. 601.8 ± 123.6 mg/dL), and fasting insulin levels were significantly increased by liraglutide (0.18 ± 0.06 ng/mL vs. 0.09 ± 0.03 ng/mL). Liraglutide completely suppressed hepatocarcinogenesis, whereas HCC was observed in all control mice (average tumor count, 5.5 ± 3.87; average tumor size, 8.1 ± 5.0 mm). Liraglutide significantly ameliorated steatosis, inflammation, and hepatocyte ballooning of non-tumorous lesions in the liver compared with the control findings, and insulin-positive β-cells were observed in the pancreas in liraglutide-treated mice but not in control mice. In conclusion, liraglutide ameliorated NASH and suppressed hepatocarcinogenesis in diabetic mice. GLP-1 receptor agonists can be used to improve the hepatic outcome of diabetes

    Fiber type analysis of lumbar muscles.

    No full text
    <p>(<b>a</b>) Immunohistochemistry for type I and type II fiber in lumbar muscles. (<b>b</b>) Comparison of fiber type percentage in lumbar muscles between normal-control-diet (NCD) and high-fat-diet (HFD) mice. Type I fiber significantly decreased (p<0.001) and type II fiber significantly increased (p<0.001) in HFD mice (<b>C</b>) Correlation between intramyocellular lipid (IMCL) and percentage of type II fiber in lumbar muscle of HFD mice. IMCL positively correlates to percentage of type II fiber in HFD mice (r = 0.80, p = 0.03).</p

    The comparison of tibialis anterior (TA) and lumbar muscles.

    No full text
    <p>Representative spectra of TA (a) and lumbar (b) muscles are shown. In both 1a and 1b, scout images (top row) indicate the location of voxels (purple boxes) in both the sagittal and axial view of leg or spinal muscles. Representative spectra (2<sup>nd</sup> row, raw data) were presented for mice in both normal-control-diet (NCD, left) and high-fat-diet (HFD, right) groups; Raw spectra were analyzed in j-MRUI software to obtain individual fitted component (3<sup>rd</sup> row, fitted data). The differences between raw data and fitted data in the 4<sup>th</sup> row (residue); Cr, indicates creatine peak (3.02ppm), and used as reference to measure intramyocellular lipid (IMCL, (1.3ppm) and extramyocellular lipid (EMCL,1.5ppm). (c) The comparison of fat accumulation with and without HFD* Indicates p<0.05. The amount of IMCL/EMCL were recorded as a ratio to Cr-peak, hence it does not associate with an actual unit (y-axis). Representative histology (d) verifies the increases of EMCLs in both TA and lumbar muscles in HFD group. The pale spaces (indicated by “*”) between red stained cell marks the presences of EMCLs, whereas IMCL is not sensitive to the histological staining.</p
    corecore